157 related articles for article (PubMed ID: 31496689)
1. Synthesis and antitumor activity of novel pyridinium fullerene derivatives.
Yasuno T; Ohe T; Ikeda H; Takahashi K; Nakamura S; Mashino T
Int J Nanomedicine; 2019; 14():6325-6337. PubMed ID: 31496689
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble fullerene derivatives for drug discovery.
Nakamura S; Mashino T
J Nippon Med Sch; 2012; 79(4):248-54. PubMed ID: 22976602
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
5. Novel pyridinium-type fullerene derivatives as multitargeting inhibitors of HIV-1 reverse transcriptase, HIV-1 protease, and HCV NS5B polymerase.
Kobayashi T; Yasuno T; Takahashi K; Nakamura S; Mashino T; Ohe T
Bioorg Med Chem Lett; 2021 Oct; 49():128267. PubMed ID: 34271071
[TBL] [Abstract][Full Text] [Related]
6. [Development of Bio-active Fullerene Derivatives Suitable for Drug].
Mashino T
Yakugaku Zasshi; 2022; 142(2):165-179. PubMed ID: 35110453
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells.
Nishizawa C; Hashimoto N; Yokoo S; Funakoshi-Tago M; Kasahara T; Takahashi K; Nakamura S; Mashino T
Free Radic Res; 2009 Dec; 43(12):1240-7. PubMed ID: 19905986
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial and antiproliferative activity of cationic fullerene derivatives.
Mashino T; Nishikawa D; Takahashi K; Usui N; Yamori T; Seki M; Endo T; Mochizuki M
Bioorg Med Chem Lett; 2003 Dec; 13(24):4395-7. PubMed ID: 14643333
[TBL] [Abstract][Full Text] [Related]
9. In vivo, in vitro and in silico anticancer investigation of fullerene C
Beyaz S; Aslan A; Gok O; Uslu H; Agca CA; Ozercan IH
Life Sci; 2022 Feb; 291():120281. PubMed ID: 34982963
[TBL] [Abstract][Full Text] [Related]
10. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
11. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678
[TBL] [Abstract][Full Text] [Related]
12. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus-reverse transcriptase inhibition activity of novel pyridine/pyridinium-type fullerene derivatives.
Yasuno T; Ohe T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2015 Aug; 25(16):3226-9. PubMed ID: 26081290
[TBL] [Abstract][Full Text] [Related]
14. Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
Dai H; Ge S; Guo J; Chen S; Huang M; Yang J; Sun S; Ling Y; Shi Y
Eur J Med Chem; 2018 Jan; 143():1066-1076. PubMed ID: 29232583
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
Cheng C; Yun F; He J; Ullah S; Yuan Q
Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
[TBL] [Abstract][Full Text] [Related]
16. P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
Joshi KS; Rathos MJ; Mahajan P; Wagh V; Shenoy S; Bhatia D; Chile S; Sivakumar M; Maier A; Fiebig HH; Sharma S
Mol Cancer Ther; 2007 Mar; 6(3):926-34. PubMed ID: 17363487
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Selenium-Containing 4-Anilinoquinazoline Derivatives as Novel Antimitotic Agents.
An B; Wang B; Hu J; Xu S; Huang L; Li X; Chan ASC
J Med Chem; 2018 Mar; 61(6):2571-2588. PubMed ID: 29509413
[TBL] [Abstract][Full Text] [Related]
18. Toward Understanding the Antitumor Effects of Water-Soluble Fullerene Derivatives on Lung Cancer Cells: Apoptosis or Autophagy Pathways?
Wong CW; Zhilenkov AV; Kraevaya OA; Mischenko DV; Troshin PA; Hsu SH
J Med Chem; 2019 Aug; 62(15):7111-7125. PubMed ID: 31361134
[TBL] [Abstract][Full Text] [Related]
19. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
